Lung Cancer Clinical Trial

Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to cancer.

PURPOSE: This research study is collecting and analyzing lung tissue samples from patients undergoing surgery for non-small cell lung cancer.

View Full Description

Full Description

OBJECTIVES:

Develop statistical and computational methods for modeling the relationships between multiple variable protein and RNA expression data and clinical endpoints using both supervised and unsupervised classification and pattern recognition approaches.
Determine protein and RNA expression fingerprints on completely resected non-small cell lung cancer without prior chemotherapy.
Correlate protein and RNA expression fingerprints with T-stage and nodal involvement at the time of surgery, and collect outcome data to allow correlation with recurrence (local and/or distant) and survival.

OUTLINE: This is a multicenter study.

Any excess tissues removed from surgery and would otherwise be discarded (tissues not used for diagnosis and/or treatment decision making) are obtained for this study. Tissue are analyzed for molecular features that predict biologic behavior. Quantitation of RNA, gene expression profiles, and protein expression patterns are assessed by matrix-assisted laser desorption/ionization time of flight mass spectroscopy and microarray analysis.

Medical records are reviewed to obtain information about results of tests associated with cancer diagnosis. Further progress in cancer treatment and tumor behavior after surgery are followed via record review.

View Eligibility Criteria

Eligibility Criteria

Inclusion criteria

Diagnosis of non-small cell lung cancer

Clinical stage I and II disease
Resectable disease and complete surgical resection planned
Treated on companion studies at Vanderbilt University, the Veterans Administration hospital, St. Thomas, and Vanderbilt-Ingram Cancer Center Affiliate Network
Tumor specimen samples must be available at resection

Exclusion criteria

Chemotherapy before surgery
Radiotherapy before surgery

Study is for people with:

Lung Cancer

Estimated Enrollment:

4000

Study ID:

NCT00897117

Recruitment Status:

Recruiting

Sponsor:

Vanderbilt-Ingram Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Dan Rudy Cancer Center at Saint Thomas Hospital
Nashville Tennessee, 37205, United States
Veterans Affairs Medical Center - Nashville
Nashville Tennessee, 37212, United States
Vanderbilt-Ingram Cancer Center
Nashville Tennessee, 37232, United States More Info
Clinical Trials Office - Vanderbilt-Ingram Cancer Center
Contact
800-811-8480

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

4000

Study ID:

NCT00897117

Recruitment Status:

Recruiting

Sponsor:


Vanderbilt-Ingram Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.